Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

--Analysis of samples for biological defense agents using Affymetrix microarray technology.

Active
USA-SNOTE-050502-008Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The U.S. Army Medical Research Acquisition Activity plans to negotiate a sole source contract with Gene Logic, Inc. to support the U.S. Army Medical Research Institute of Infectious Diseases by providing comprehensive services including quality control, processing, labeling, gene expression data generation, and detailed data analysis of biological samples. These samples, prepared by USAMRIID, will be analyzed using Affymetrix microarray technology to identify candidate biomarkers that differentiate responses to vaccines or infectious agents. The contractor must possess specialized capabilities to predict compound toxicity through established biomarker profiles and have access to an extensive database that enables screening for biomarker specificity and cross-reactivity, helping to minimize false positives when distinguishing exposure to biological agents from other disease conditions. Gene Logic, Inc. is considered uniquely qualified due to its extensive biomarker library relevant to virus-like particles such as Ebola and Marburg viruses, along with other biological agents and vaccines. Companies interested in competing must demonstrate their qualifications with detailed evidence within 15 days of the notice’s publication, although the current intention is to proceed with a sole source award if no competing responses are received by the specified deadline. The contract will enhance biological defense research by leveraging Gene Logic’s comprehensive data resources and analytical expertise in a niche area critical to biodefense and public health monitoring.

General Info

Gene Logic awarded sole source contract for biomarker analysis supporting US Army infectious disease research.

Agency

N/A

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

special-notice

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyN/A
ContactsNo contacts available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
The U.S. Army Medical Research Acquisition Activity (USAMRAA) intends to negotiate a sole source contract with Gene Logic, Inc., 610 Professional Drive, Gaithersburg, Maryland 20879. The procurement will provide the U.S. Army Medical Research Instit ute of Infectious Diseases (USAMRIID) with the Quality Control, processing, labeling, gene expression data generation, and data analysis (identification of candidate biomarkers based on significantly changing genes, if any, in the samples that would differ entiate responses between experimental groups treated with vaccine or infectious agent) of samples to be delivered and prepared by USAMRIID using a protocol suitable for use in Affymetrix microarray technology. The contractor must have the ability to predict toxicity of compounds based on a well defined set of biomarkers for toxicity. It is believed that Gene Logic, Inc. is the only company with a library to detect changes with virus-like-particles of Ebola/Marb urg and other biological agents and vaccines. The contractor must be able to screen biomarkers for specificity and cross reactivity against an extensive pre-existing database to allow quick elimination of biomarkers that could also be expressed in other c ommon disease conditions and thus lead to false positives. For example, a biomarker for exposure to Anthrax may also be expressed in patients with pulmonary emphysema. It would be necessary to know of such co-occurrences to minimize the number of false p ositives when screening large populations for exposure to biological agents. It is believed that Gene Logic, Inc. uniquely offers the breadth and depth of data necessary for screening biomarkers for this level of specificity. Any company that believes that it can meet these requirements is invited to submit written notification to the Contract Specialist within 15 calendar days from the date of the publication of this notice. Supporting evidence must be furnished in sufficient detail to demonstrate the company's ability to meet the requirement. Information can be sent by email to the Contract Specialist at: contact@example.gov. The notice of intent is not a request for competitive quotes. However, responses received fro m responsible businesses prior to close of business on 17 May 2005 will be evaluated. If no responses are received, USAMRAA will proceed with the sole source contract.

Similar Contracts

Same NAICS industry code

Earlier notices in this NAICS code

Posted before this notice, open and closed

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS